Drug Master Files for: SIMVASTATIN
✉ Email this page to a colleague
SIMVASTATIN Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
14599 | A | II | 11/29/1999 | TEVA PHARMACEUTICAL INDUSTRIES LTD | SIMVASTATIN |
15722 | I | II | 11/7/2001 | SUN PHARMACEUTICAL INDUSTRIES LTD | SIMVASTATIN USP |
16094 | I | II | 8/12/2002 | BIOCON LTD | SIMVASTATIN USP |
16305 | A | II | 12/11/2002 | ZHEJIANG HISUN PHARMACEUTICAL CO LTD | SIMVASTATIN USP |
17151 | I | II | 2/10/2004 | KREBS BIOCHEMICALS INDUSTRIES LTD | SIMVASTATIN USP |
17568 | I | II | 7/27/2004 | LEK PHARMACEUTICALS DD | SIMVASTATIN |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information